{
    "clinical_study": {
        "@rank": "139682", 
        "acronym": "LOBI-BBB", 
        "biospec_descr": {
            "textblock": "2x 2ml plasma and 2x 2ml serum per patient"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The objective of this trial is to visualize blood brain barrier function and metabolic\n      changes in the first days after ischemic stroke with new investigational MRI sequences."
        }, 
        "brief_title": "Longitudinal MRI Examinations of Patients With Brain Ischemia and Blood Brain Barrier Permeability", 
        "completion_date": {
            "#text": "December 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Cerebral Stroke", 
        "condition_browse": {
            "mesh_term": [
                "Brain Ischemia", 
                "Ischemia", 
                "Stroke", 
                "Cerebral Infarction"
            ]
        }, 
        "detailed_description": {
            "textblock": "In this study the investigators will be examining acute ischemic stroke patients on the\n      first and second day after symptom onset using repetitive MRI examinations to visualize\n      blood brain barrier function and metabolic changes of the brain in 5 sub-projects, each\n      containing a specific MRI protocol with one of the following new MRI sequences:\n\n        1. T1-Dynamics (measuring disruptions of the blood-brain barrier)\n\n        2. pH-imaging (measuring metabolic changes, acidosis)\n\n        3. Resting-state MRI (measuring changes in the cerebral perfusion)\n\n        4. Quantitative MRI-Angiography (quantification of blood flow in single vessels)\n\n        5. Diffusion Tensor Imaging (DTI) for patients with Anterior Choroidal Artery\n           (AChA)-Infarcts (quantification of damage of white matter tracts)\n\n      Each sub-projects will be conducted in blocks of a specific time span. Morphological outcome\n      will be assessed at day 5-7. Clinical outcome will be assessed at day 5-7 and day 90. The\n      association of the new imaging parameter with the clinical and morphological outcome\n      measures will be analysed. No specific intervention is assigned to the subjects by the\n      investigators of the study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Suspected stroke or transient ischemic attack (TIA) within 24h from symptom onset\n\n        Exclusion Criteria:\n\n          -  MRI contraindication, age < 18 years, intracranial hemorrhages"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Primary care clinic. Patients presenting with acute (<24h) transient ischemic attack or\n        stroke at the emergency ward, Charit\u00e9 Campus Benjamin Franklin"
            }
        }, 
        "enrollment": {
            "#text": "410", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02077582", 
            "org_study_id": "LOBI-BBB", 
            "secondary_id": "EA1/200/13"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "acute ischemic stroke", 
        "lastchanged_date": "March 3, 2014", 
        "link": {
            "description": "Homepage Center for Stroke Research", 
            "url": "http://schlaganfallcentrum.de/index.php?id=147"
        }, 
        "location": {
            "contact": {
                "email": "jochen.fiebach@charite.de", 
                "last_name": "Jochen B. Fiebach, MD", 
                "phone": "004930 8445 4088"
            }, 
            "facility": {
                "address": {
                    "city": "Berlin", 
                    "country": "Germany", 
                    "zip": "12203"
                }, 
                "name": "Center for Stroke Research Berlin, Charit\u00e9 Universit\u00e4tsmedizin Berlin, Campus Benjamin Franklin"
            }, 
            "investigator": [
                {
                    "last_name": "Jochen B. Fiebach, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Kersten Villringer, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Ann-Christin Ostwaldt, MSc", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Ivana Galinovic, MD PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Benjamin Hotter, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Lars Neeb, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Claudia E. Kunze", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Ramanan Ganeshan, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Peter Brunecker, PhD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "1", 
        "official_title": "Longitudinal Observation of Brain Ischemia and Blood Brain Barrier Permeability in the Acute Phase of Ischemic Stroke", 
        "other_outcome": [
            {
                "description": "outcome measure for resting state-MRI sub-project only", 
                "measure": "volumes of hypoperfusion on resting state-MRI perfusion maps", 
                "safety_issue": "No", 
                "time_frame": "on follow-up examinations day 1 and 2"
            }, 
            {
                "description": "outcome measure for quantitative Angiography sub-project only", 
                "measure": "blood flow parameters in occluded, contralateral and (partially) recanalized vessels", 
                "safety_issue": "No", 
                "time_frame": "on follow-up examinations day 1 and 2"
            }, 
            {
                "description": "outcome measure for the pH-Imaging sub-project only", 
                "measure": "pH values in the region of diffusion restriction and in the region of final infarct", 
                "safety_issue": "No", 
                "time_frame": "on follow-up examinations day 1 and 2"
            }, 
            {
                "description": "outcome measure for the T1-Dynamic sub-project only", 
                "measure": "quantified values for contrast agent enhancement in the stroke lesion and on the contralateral side", 
                "safety_issue": "No", 
                "time_frame": "on follow-up examination day 1 and 2"
            }
        ], 
        "overall_contact": {
            "email": "jochen.fiebach@charite.de", 
            "last_name": "Jochen B: Fiebach, MD", 
            "phone": "004930 8445 4088"
        }, 
        "overall_contact_backup": {
            "email": "kersten.villringer@charite.de", 
            "last_name": "Kersten Villringer, MD", 
            "phone": "004930 8445 4080"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "clinical outcome measured with the National Institutes of Health Stroke Scale (NIHSS)", 
                "safety_issue": "No", 
                "time_frame": "on follow-up examination day 5-7"
            }, 
            {
                "description": "conducted as  telephone interview", 
                "measure": "clinical outcome measured with the modified Rankin Scale (mRS)", 
                "safety_issue": "No", 
                "time_frame": "on day 90"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02077582"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Charite University, Berlin, Germany", 
            "investigator_full_name": "Jochen B. Fiebach", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "final lesion volume (measured on FLAIR images)", 
            "safety_issue": "No", 
            "time_frame": "on follow-up examination day 5-7"
        }, 
        "source": "Charite University, Berlin, Germany", 
        "sponsors": {
            "collaborator": {
                "agency": "German Federal Ministry of Education and Research", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Charite University, Berlin, Germany", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}